Nuzenio

Advanced Urothelial Carcinoma

Advanced Urothelial Carcinoma news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

New Combination Therapy Shows Promise for Advanced Bladder Cancer - CU Anschutz newsroomCU Anschutz newsroom · Thu, 06 Aug 2026 19:16:18 GMT Sequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma - OncodailyOncodaily · Thu, 06 Aug 2026 14:43:41 GMT Enfortumab Vedotin–Related Skin Toxicities Predict Better Survival in Advanced Urothelial Cancer: JAMA - Medical DialoguesMedical Dialogues · Wed, 05 Aug 2026 14:30:55 GMT Camrelizumab Plus Nab-Paclitaxel Yields Efficacy in Previously Treated Advanced Urothelial Carcinoma - OncLiveOncLive · Tue, 04 Aug 2026 15:51:00 GMT Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 19:16:18 GMTNew Combination Therapy Shows Promise for Advanced Bladder Cancer - CU Anschutz newsroom

Thu, 06 Aug 2026 14:43:41 GMTSequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma - Oncodaily

Wed, 05 Aug 2026 14:30:55 GMTEnfortumab Vedotin–Related Skin Toxicities Predict Better Survival in Advanced Urothelial Cancer: JAMA - Medical Dialogues

Tue, 04 Aug 2026 15:51:00 GMTCamrelizumab Plus Nab-Paclitaxel Yields Efficacy in Previously Treated Advanced Urothelial Carcinoma - OncLive

Tue, 28 Jul 2026 07:00:00 GMTLantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Yahoo Finance

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.

Connected entities

CU Anschutz3 live mentions New Combination Therapy2 live mentions Shows Promise2 live mentions Advanced Bladder Cancer2 live mentions Vedotin2 live mentions Pembrolizumab2 live mentions Enfortumab Vedotin2 live mentions Related Skin Toxicities2 live mentions Predict Better Survival2 live mentions Advanced Urothelial Cancer2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Advanced Urothelial Carcinoma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.